Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 13210 | 788 | 28.5 | 60% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 233 | 19645 | BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TOTAL BODY IRRADIATION | Author keyword | 27 | 22% | 14% | 108 |
| 2 | TOTAL MARROW IRRADIATION | Author keyword | 19 | 63% | 2% | 19 |
| 3 | OCULAR GRAFT VERSUS HOST DISEASE | Author keyword | 18 | 89% | 1% | 8 |
| 4 | TOTAL BODY IRRADIATION TBI | Author keyword | 11 | 54% | 2% | 14 |
| 5 | OCULAR GVHD | Author keyword | 9 | 83% | 1% | 5 |
| 6 | FRACTIONATED TOTAL BODY IRRADIATION | Author keyword | 4 | 67% | 1% | 4 |
| 7 | HYPERFRACTIONATED TBI | Author keyword | 3 | 100% | 0% | 3 |
| 8 | KOMPETENZZENTRUM OKULARE GVHD | Address | 3 | 100% | 0% | 3 |
| 9 | INSTANTANEOUS DOSE RATE | Author keyword | 3 | 60% | 0% | 3 |
| 10 | CALCAREOUS CORNEAL DEGENERATION | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GUIDED TOTAL MARROW | 32 | 80% | 3% | 20 |
| 2 | HOSPITAL UCL GROUP | 11 | 100% | 1% | 6 |
| 3 | LONDON 1988 1993 | 11 | 100% | 1% | 6 |
| 4 | TOPICAL CYCLOSPORINE 005 PERCENT | 6 | 58% | 1% | 7 |
| 5 | INSTANTANEOUS DOSE RATES | 6 | 100% | 1% | 4 |
| 6 | SEVERE DRY EYE | 4 | 29% | 1% | 11 |
| 7 | TOTAL MARROW IRRADIATION | 4 | 36% | 1% | 8 |
| 8 | OCULAR COMPLICATIONS | 3 | 12% | 3% | 21 |
| 9 | SCLERAL LENS | 2 | 67% | 0% | 2 |
| 10 | AFFECTS PROGNOSIS | 1 | 100% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Graft versus host disease: clinical evaluation, diagnosis and management | 2013 | 10 | 47 | 38% |
| Total body irradiation and pneumonitis risk: a review of outcomes | 2004 | 20 | 26 | 73% |
| Ocular graft-versus-host disease | 2012 | 12 | 56 | 38% |
| TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions | 2011 | 16 | 55 | 31% |
| Ocular Graft-versus-Host Disease: A Review | 2013 | 10 | 161 | 21% |
| American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Total Body Irradiation (TBI) | 2013 | 2 | 21 | 38% |
| Radiobiological modelling of the treatment of leukaemia by total body irradiation | 2001 | 8 | 10 | 60% |
| Ocular Graft-Versus-Host Disease: A Review | 2015 | 0 | 46 | 52% |
| Non-endocrine late complications of bone marrow transplantation in childhood: part II | 2002 | 30 | 162 | 19% |
| Mucosal graft-vs-host disease | 2007 | 7 | 89 | 26% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | KOMPETENZZENTRUM OKULARE GVHD | 3 | 100% | 0.4% | 3 |
| 2 | EXZELLENZCLUSTER CELLULAR ST S PONSE AGING A | 1 | 100% | 0.3% | 2 |
| 3 | BHAGWAN MAHAVIR VITREORETINAL SERV | 1 | 50% | 0.1% | 1 |
| 4 | BONE MARROW TRANSPLANTAT LEUKEMIA SECT | 1 | 50% | 0.1% | 1 |
| 5 | HEMATOL INTERNAL ONCOL HEMOSTASEOL | 1 | 50% | 0.1% | 1 |
| 6 | MASSACHUSETTS EYE EAR ASSOCIATES | 1 | 50% | 0.1% | 1 |
| 7 | MINNESOTA SUPER COMP | 1 | 50% | 0.1% | 1 |
| 8 | RADIOTHER Y HIGH ENERGY | 1 | 50% | 0.1% | 1 |
| 9 | JJ OCULAR SUR E VISUAL OPT | 0 | 13% | 0.4% | 3 |
| 10 | ACUTE LEUKEMIA WORKING PARTY OFF | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000166667 | BUSULFAN//TREOSULFAN//INTRAVENOUS BUSULFAN |
| 2 | 0.0000165520 | IDIOPATHIC PNEUMONIA SYNDROME//BRONCHIOLITIS OBLITERANS//LATE ONSET NONINFECTIOUS PULMONARY COMPLICATIONS |
| 3 | 0.0000119557 | BONE MARROW PURGING//MARROW PURGING//MAFOSFAMIDE |
| 4 | 0.0000114918 | GENITAL GVHD//CARDIAC LATE EFFECTS//HCT HEMATOPOIETIC CELL TRANSPLANTATION |
| 5 | 0.0000110829 | RADIATION NEPHROPATHY//SCHISTOCYTE//RADIATION NEPHRITIS |
| 6 | 0.0000098452 | DLA DRB1//CANINE MAJOR HISTOCOMPATIBILITY COMPLEX//DLA DQA1 |
| 7 | 0.0000096354 | GRAFT VERSUS HOST DISEASE//CHRONIC GRAFT VERSUS HOST DISEASE//GVHD |
| 8 | 0.0000091063 | VETO CELLS//VETO//L LEUCYL L LEUCINE METHYL ESTER |
| 9 | 0.0000080873 | JIXUETENG//SPATHOLOBUS SUBERECTUS DUNN//CHRONIC LOW DOSE IRRADIATION |
| 10 | 0.0000077201 | SCLERAL CONTACT LENSES//SCLERAL LENS//SCLERAL CONTACT LENS |